ATR and cancer: In cells depleted of SMC5/6, we did not find a difference in phosphorylation of Chk1 at ATR-dependent sites (Appendix Fig. S2i), suggesting that SMC5/6 loss does not alter ATR signaling in the cancer cells tested.